Aptus Pharma Limited (BOM:544529)
India · Delayed Price · Currency is INR 221.95
+3.95 (1.81%)
At close: Jan 16, 2026
Aptus Pharma Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2019 - 2020 |
| 291.8 | 245.58 | 178.57 | 138.97 | 105.07 | 50.96 | Upgrade | |
Revenue Growth (YoY) | 109.97% | 37.52% | 28.49% | 32.27% | 106.18% | 4.67% | Upgrade |
Cost of Revenue | 111.6 | 90.37 | 68.26 | 47.63 | 38.31 | 16.93 | Upgrade |
Gross Profit | 180.19 | 155.21 | 110.31 | 91.35 | 66.76 | 34.03 | Upgrade |
Selling, General & Admin | 71.21 | 63.56 | 43.21 | 30.37 | 26.39 | 12.6 | Upgrade |
Other Operating Expenses | 50.69 | 43.16 | 51.2 | 54.41 | 37.05 | 19.61 | Upgrade |
Operating Expenses | 125.04 | 109.37 | 96.53 | 86.58 | 64.39 | 32.64 | Upgrade |
Operating Income | 55.15 | 45.84 | 13.78 | 4.76 | 2.37 | 1.4 | Upgrade |
Interest Expense | -6.43 | -2.98 | -1.6 | -0.99 | -0.84 | -0.57 | Upgrade |
Interest & Investment Income | 0.77 | 0.77 | 0.25 | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | -1.59 | -1.68 | -0.79 | -0.44 | -0.07 | -0.19 | Upgrade |
EBT Excluding Unusual Items | 47.91 | 41.95 | 11.64 | 3.33 | 1.46 | 0.64 | Upgrade |
Pretax Income | 47.91 | 41.95 | 11.64 | 3.33 | 1.46 | 0.64 | Upgrade |
Income Tax Expense | 12.5 | 10.96 | 3.04 | 0.9 | 0.45 | 0.25 | Upgrade |
Net Income | 35.41 | 31 | 8.6 | 2.43 | 1.01 | 0.38 | Upgrade |
Net Income to Common | 35.41 | 31 | 8.6 | 2.43 | 1.01 | 0.38 | Upgrade |
Net Income Growth | 1358.65% | 260.45% | 254.23% | 140.83% | 163.41% | 285.15% | Upgrade |
Shares Outstanding (Basic) | 7 | 5 | 2 | 1 | 1 | 1 | Upgrade |
Shares Outstanding (Diluted) | 7 | 5 | 2 | 1 | 1 | 1 | Upgrade |
Shares Change (YoY) | 861.91% | 224.21% | 105.42% | -0.02% | 16.87% | - | Upgrade |
EPS (Basic) | 5.04 | 6.37 | 5.73 | 3.32 | 1.38 | 0.61 | Upgrade |
EPS (Diluted) | 5.04 | 6.37 | 5.73 | 3.32 | 1.38 | 0.61 | Upgrade |
EPS Growth | 51.62% | 11.13% | 72.44% | 140.87% | 125.39% | 285.15% | Upgrade |
Free Cash Flow | - | -24.6 | -25.04 | -5.34 | - | -1.5 | Upgrade |
Free Cash Flow Per Share | - | -5.06 | -16.69 | -7.31 | - | -2.40 | Upgrade |
Gross Margin | 61.75% | 63.20% | 61.77% | 65.73% | 63.54% | 66.79% | Upgrade |
Operating Margin | 18.90% | 18.67% | 7.72% | 3.43% | 2.26% | 2.74% | Upgrade |
Profit Margin | 12.13% | 12.62% | 4.82% | 1.75% | 0.96% | 0.75% | Upgrade |
Free Cash Flow Margin | - | -10.02% | -14.02% | -3.84% | - | -2.94% | Upgrade |
EBITDA | 58.34 | 48.49 | 15.92 | 6.57 | 2.8 | 1.82 | Upgrade |
EBITDA Margin | 19.99% | 19.75% | 8.92% | 4.73% | 2.67% | 3.58% | Upgrade |
D&A For EBITDA | 3.19 | 2.65 | 2.15 | 1.81 | 0.43 | 0.43 | Upgrade |
EBIT | 55.15 | 45.84 | 13.78 | 4.76 | 2.37 | 1.4 | Upgrade |
EBIT Margin | 18.90% | 18.67% | 7.72% | 3.43% | 2.26% | 2.74% | Upgrade |
Effective Tax Rate | 26.09% | 26.11% | 26.10% | 27.10% | 31.06% | 39.85% | Upgrade |
Revenue as Reported | 292.67 | 246.36 | 178.82 | 138.97 | 105.07 | 50.96 | Upgrade |
Advertising Expenses | - | 27.36 | 20.61 | 15.24 | 17.21 | 8.14 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.